4.7 Article

Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer

出版社

ENDOCRINE SOC
DOI: 10.1210/clinem/dgad185

关键词

diffuse sclerosing papillary thyroid cancer; papillary thyroid cancer; gene panel; mutations; fusion genes

向作者/读者索取更多资源

In this study, the molecular genetics of DSPTC were investigated. It was found that fusion genes were common in DSPTC, while BRAF(V600E) was rare and other common point mutations were absent.
Context Diffuse sclerosing papillary thyroid cancer (DSPTC) is rare, with limited data on its molecular genetics. Objective We studied the molecular genetics of a cohort of DSPTC. Methods DNA was isolated from paraffin blocks of 22 patients with DSPTC (15 females, 7 males, median age 18 years, range 8-81). We performed polymerase chain reaction-based Sanger sequencing and a next-generation sequencing (NGS) gene panel to characterize the genomic landscape of these tumors. We classified genetic alterations to definitely or probably pathogenic. Definitely pathogenic are genetic alterations that are well known to be associated with PTC (e.g., BRAF(V600E)). Probably pathogenic are other alterations in genes that were reported in The Cancer Genome Atlas or the poorly differentiated and anaplastic thyroid cancer datasets. Results Three tumors were tested only by Sanger sequencing and were negative for BRAF(V600E), HRAS, KRAS, NRAS, TERT promoter, PTEN, and PIK3CA mutations. The other 19 tumors tested by NGS showed definitely pathogenic alterations in 10 patients (52.6%): 2/19 (10.5%) BRAF(V600E), 5/19 (26.3%) CCDC6-RET (RET/PTC1), 1/19 (5.3%) NCOA4-RET (RET/PTC3), 1/19 (5.3%) STRN-ALK fusion, and 2/19 (10.6%) TP53 mutations. Probably pathogenic alterations occurred in 13/19 tumors (68.4%) and included variants in POLE (31.6%), CDKN2A (26%), NF1 (21%), BRCA2 (15.8%), SETD2 (5.3%), ATM (5.3%), FLT3 (5.3%), and ROS1 (5.3%). In 1 patient, the gene panel showed no alterations. No mutations were found in the RAS, PTEN, PIK3CA, or TERT promoter in all patients. There was no clear genotype/phenotype correlation. Conclusion In DSPTC, fusion genes are common, BRAF(V600E) is rare, and other usual point mutations are absent. Pathogenic and likely pathogenic variants in POLE, NF1, CDKN2A, BRCA2, TP53, SETD2, ATM, FLT3, and ROS1 occur in about two-thirds of DTPTC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据